Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PKU Healthcare is a prominent Chinese pharmaceutical company that integrates research and development, manufacturing, and pharmaceutical distribution. Formerly a core member of the Peking University Founder Group, the company is now a key healthcare asset of the China Ping An group following a comprehensive corporate restructuring. Its core business focuses on chemical drugs, particularly in therapeutic areas such as anti-infectives, cardiovascular treatments, psychiatry, and oncology. PKU Healthcare operates large-scale manufacturing bases in Chongqing and has successfully passed numerous generic drug consistency evaluations in China. Beyond pharmaceuticals, the company is also involved in medical service provision and hospital supply chain management, leveraging its connection to major academic and financial institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PKU Healthcare.